The Column Group

The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early stage drug discovery companies based on their unique scientific platforms and potential to deliver multiple breakthrough therapeutics. TCG’s investment strategy runs counter to the prevailing trend in life sciences venture capital toward assembling diversified portfolios of later stage, single product-orientated companies across multiple industry sectors, with proximity to value inflection points and the early identification of a Pharma “buyer” as key investment considerations. In contrast, TCG takes the long view in making investments, recognizing that significant time is often required to generate significant value. Our approach is not “building-to-exit.” Key variables, including scientific opportunities, the competitive and regulatory landscape, and Pharma priorities, can change very rapidly. Instead, TCG’s mission is the generation of fundament…

San Francisco, California, United States11-50 employeesFounded 2006

Overview

The Column Group is a venture capital firm dedicated to creating the next generation of biotechnology companies. They manage over $4 billion in assets and focus on building companies with groundbreaking scientific platforms that have the potential to deliver significant new therapies for unmet medical needs. TCG takes a long-term approach, aiming to develop companies capable of generating multiple product opportunities rather than focusing on quick exits.

Tech Stack

DnssecHstsGlobal site tagCommoncrawl top 5mCommoncrawl top 100mCloudflare jsCdn jsAmazon s3Aws global acceleratorCloudflare bot managerAIApacheBootstrap FrameworkData AnalyticsEasyDNSGoDaddy HostingGoogle AnalyticsGoogle Font APIGoogle Tag ManagerGreenhouse.ioMicrosoft Office 365Mobile FriendlyOutlookRackspace MailGunRemoteWordPress.orgReCAPTCHA

Rotate Your Device

Overview

Tech Stack